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In vitro evolution of Pseudomonas 
aeruginosa AA2 biofilms in the 
presence of cystic fibrosis lung 
microbiome members
eva Vandeplassche1, Andrea Sass  1, Astrid Lemarcq1, Ajai A. Dandekar  2, Tom Coenye  1 & 
Aurélie Crabbé  1
In cystic fibrosis (CF) airways, the opportunistic pathogen Pseudomonas aeruginosa evolves from an 
acute to a chronic infection phenotype. Yet, the in vivo factors influencing the evolutionary trajectory 
of P. aeruginosa are poorly understood. This study aimed at understanding the role of the CF lung 
microbiome in P. aeruginosa evolution. Therefore, we investigated the in vitro biofilm evolution of an 
early CF P. aeruginosa isolate, AA2, in the presence or absence of a synthetic CF lung microbiome. Whole 
genome sequencing of evolved populations revealed mutations in quorum sensing (QS) genes (lasR, 
pqsR) with and without the microbiome. Phenotypic assays confirmed decreased production of the QS 
molecule 3-O-C12-homoserine lactone, and QS-regulated virulence factors pyocyanin and protease. 
Furthermore, a mixture of lasR and lasR pqsR mutants was found, in which double mutants showed 
less pyocyanin and protease production than lasR mutants. While the microbial community did not 
influence the production of the tested P. aeruginosa virulence factors, we observed a trend towards 
more mutations in the transcriptional regulators gntR and mexL when P. aeruginosa was grown alone. 
P. aeruginosa developed resistance to β-lactam antibiotics during evolution, when grown with and 
without the microbiome. In conclusion, in an experimental biofilm environment, the early P. aeruginosa 
CF isolate AA2 evolves towards a CF-like genotype and phenotype, and most studied evolutionary 
adaptations are not impacted by CF microbiome members.
Pseudomonas aeruginosa is a Gram-negative, versatile, opportunistic pathogen that causes chronic lung infec-
tions in cystic fibrosis (CF) patients1–3. Because of its large genome – over 6 Mb and almost 6000 genes – it is 
able to quickly adapt to, and hence thrive in, different environments and stress conditions4,5. In the CF airways, 
a characteristic evolutionary adaption of P. aeruginosa is observed with a gradual transition from an ‘acute’ phe-
notype (characterized by motility, protease production, and type III secretion) to a ‘chronic’ phenotype (char-
acterized by biofilm formation, decreased antibiotic susceptibility, loss of virulence factor production, altered 
pro-inflammatory effect, and hypermutability)5–12. This adaptation is thought to be due to a combination of selec-
tive pressures present in the CF lungs, i.e. viscous mucus, hyperinflammation, prolonged antibiotic treatment, the 
presence of bacteriophages and a complex microbial community4,7. Moreover, an intra-patient phenotypic diver-
sity of P. aeruginosa isolates has been observed in CF patients13–16, which is possibly due to regional adaptation in 
the spatially heterogeneous lung environment5,17,18.
One of the key features of P. aeruginosa evolution in the CF lung is the emergence of mutations in the las 
quorum sensing (QS) system, which are associated with a loss in production of virulence factors, such as pro-
teases and exotoxins19–21. QS in P. aeruginosa consists of multiple interrelated signalling circuits. There are three 
acyl-homoserine lactone responsive transcription factors, LasR, RhlR, and QscR; and a quinolone-responsive 
transcripton factor called PqsR. The las system sits at the top of this complex hierarchy22. Multiple other pathoad-
aptive mutations have also been associated with chronic P. aeruginosa infection, such as mutations in gacS, retS, 
rpoN, ampR, mexT and mucA5. During in vitro planktonic and biofilm evolution studies, mutations in the lasR 
gene, coding for the transcriptional regulator of the las QS system, have repeatedly been observed and these have 
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been associated with increased antibiotic resistance8,23–26. However, most of these studies have focused solely on 
the evolution of P. aeruginosa in single culture, and do not take into account the complex bacterial community 
present in the CF airways in vivo27–29. This CF lung microbiome can contain various pathogens besides P. aerugi-
nosa (e.g. Staphylococcus aureus, Haemophilus influenzae. Burkholderia cenocepacia, Achromobacter xylosoxidans, 
Streptococcus milleri group bacteria and Stenotrophomonas maltophilia) as well as other non-pathogenic bacteria 
(including Rothia mucilaginosa and Gemella haemolysans)28,30–32. However, whether the characteristic phenotypic 
and genotypic adaptation of P. aeruginosa in the course of chronic infection of the respiratory tract of people with 
CF, including hallmark mutations in the QS system, is influenced by the presence of this complex microbial com-
munity is unclear. This is of particular importance since the QS system is involved in the competitive behaviour of 
P. aeruginosa33,34. Production of many virulence factors, such as pyocyanin, hydrogen cyanide, elastase and rham-
nolipids, that exert antimicrobial activity against other bacteria, are QS-regulated33,35–38. In addition, QS partially 
contributes to the regulation of siderophores (such as pyoverdine) that are important in competition for iron.
We performed a biofilm evolution study using the early CF P. aeruginosa isolate AA2. P. aeruginosa was cul-
tured in vitro in a biofilm during 54 days (18 cycles of 72 h biofilm formation) in the absence and presence of a 
microbial community comprised of commonly isolated species in the CF lung. Whole genome sequencing (WGS) 
was performed to unravel genotypic differences and phenotypic tests were carried out to investigate changes 
in production of various virulence factors (i.e. phenazines, proteases, rhamnolipids), antibiotic susceptibility, 
growth, motility, and competitive behaviour. Furthermore, the pro-inflammatory response of human epithelial 
cells to evolved versus unevolved P. aeruginosa strains was examined in a differentiated 3-D lung epithelial cell 
model.
Materials and Methods
Bacterial strains and culturing conditions. Bacterial strains used are shown in Table S1 and were cul-
tured on solid media as described before39. For the evolution study, liquid cultures of each bacterial strain were 
grown until stationary phase in BHI broth (37 °C, 250 rpm; Table S1). S. anginosus and G. haemolysans cultures 
were incubated in microaerophilic conditions (CampyGen Compact system, Thermo Fisher Scientific, USA).
For phenotypic testing and sequencing of evolved populations originating from the biofilm evolution exper-
iment, an aliquot of the frozen biofilm (stored as glycerol stock at −80 °C) was plated on LB agar and incubated 
overnight at 37 °C. The entire growth on the agar plate was then divided into two Microbank cryovials with beads 
(Pro-Lab Diagnostics) and frozen at −80 °C. A single bead was then used to inoculate 5 ml LB broth (incubated 
at 37 °C, 250 rpm, 16 hours) to serve as inoculum for phenotypic tests and DNA extraction. These cultures are 
designated “evolved populations” throughout the text for the sake of clarity.
Biofilm evolution model set-up. A Multiscreen 96-well system (Millipore, Merck KGaA, Germany) con-
sisting of a sterile filter plate with 0.22 µm PVDF filter membranes and a transport receiver plate (sterilized by 
1 hour exposure to UV light) was used for biofilm formation of P. aeruginosa AA2 in the absence or presence of 
the other microbiome members (Fig. 1A). All bacterial suspensions were diluted in BHI medium supplemented 
with 2.5% lysed horse blood (BHI + LYS) (Biotrading, The Netherlands; lysed horse blood stock according to 
EUCAST protocol40). For the initiation of the evolution study (first cycle, T1), 100 µL of P. aeruginosa suspen-
sion (approx. 5 × 106 CFUs of starting/unevolved culture) was transferred to the upper filter plate, and 300 µL of 
microbiome community culture (containing approx. 5 × 106 CFUs of each strain, i.e. S. aureus, S. anginosus, A. 
xylosoxidans, R. mucilaginosa, and G. haemolysans) or 300 µL of medium (control) was transferred to the receiver 
plate. This way, no physical contact between P. aeruginosa and the other bacterial species occurred, yet medium 
containing soluble secreted products could migrate through the 0.22 µm low protein-binding filter. Then, cultures 
were incubated in microaerophilic conditions (±5% O2, ±15% CO2; CampyGen Compact system, Thermo Fisher 
Scientific) for 72 hours (3 days). After 3 days of culture, P. aeruginosa AA2 biofilm cells were removed from the 
filter plate. First, a wash step with physiological saline (PS; 0.9% [w/v] NaCl in MilliQ water) was performed after 
which two rounds of vortexing and sonication resulted in homogenized P. aeruginosa biofilm cells, as described 
before39. The colony forming units (CFU) in the biofilm were quantified by microdilution plating on LB agar. A 
fraction of the biofilm was stored at −80 °C (in PS containing a final concentration of 20% glycerol) until further 
genomic and phenotypic experiments were conducted. To initiate the second cycle and for each cycle hereafter 
(T2 – T18), the homogenized biofilm was diluted 1/40 in BHI + LYS (resulting in ±5 × 106 CFUs) and transferred 
to the filter plate. The microbial community was added to the transport receiver plate as described above for the 
first cycle. This was repeated 18 cycli representing a total of 54 days. Three independent lineages were cultured 
in parallel which were started from three different P. aeruginosa AA2 stationary phase cultures; each lineage was 
cultured in the presence and absence of the microbiome members (Fig. 1B).
DNA extraction and sequencing. Genomic DNA extraction: glass-bead protocol. Genomic DNA was 
extracted from 2 mL planktonic stationary phase cultures of the unevolved strain (T0, initial culture) or evolved 
populations of P. aeruginosa AA2. After centrifugation, the pellet was resuspended in 200 µL TE buffer (10 mM 
Tris-HCl pH 8 + 1 mM EDTA pH 8). Of this, 100 µL was added to lysis tubes containing 500 µL acid-washed glass 
beads (Sigma-Aldrich, USA) and 500 µL lysis buffer (50 mM Tris-HCl pH 8, 70 mM EDTA pH 8, 1% sodium 
dodecyl sulfate) with 0.5 µg/mL pronase (Roche, Germany). After vortexing, the tubes were incubated at 37 °C for 
1 hour and then pulse-spinned. Afterwards, 200 µL saturated ammonium acetate was added, vortexed again, and 
spinned for 2 minutes. 600 µL chloroform was added, the mixture was vortexed, and then centrifuged for 5 min-
utes to separate the phases. Then, 400 µL of the top aqueous phase was transferred to a new tube containing 1 mL 
100% ethanol. This was mixed by inversion and centrifuged for 5 minutes. The supernatant was removed, washed 
with 70% ethanol, and air-dried. The resulting DNA was dissolved in low-EDTA-TE buffer (10 mM Tris-HCl pH 
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8 + 0.1 mM EDTA pH 8 + 0.5 µg/mL RNase A (Qiagen, Germany)) and the concentration measured using the 
BioDrop µLITE (Isogen Life Science, The Netherlands).
Whole genome sequencing (WGS) and bioinformatics analysis. WGS libraries were prepared with the 
NEBNext kit (New England Biolabs, Ipswich, USA) and sequenced on the Illumina Nextseq 500 platform 
(Oxford Genomics Center, University of Oxford, United Kingdom), yielding 5 to 9 million 150 bp paired end 
reads per sample. Demultiplexed raw reads were imported into CLC Genomics Workbench 11.0.1 (QIAGEN 
Bioinformatics, Aarhus, Denmark) for all further analysis steps. Reads were quality-trimmed (error probability 
limit 0.05, reads < 15 nt were discarded) and the input strain sample (T0) was de novo assembled (word size 22, 
bubble size 55, mismatch cost 2, insertion and deletion cost 2, length fraction 0.5, similarity fraction 0.8), gen-
erating 92 contigs (total length 6244190, N50 = 210536, max length 471773, average coverage 123.5). The RAST 
annotation engine41 was used to annotate the consensus sequence of contigs. The reads derived from the evolved 
populations were then mapped to all contigs, with cut-offs 0.5 for length fraction, and 0.8 for similarity fraction 
for mapped reads. Mapping parameters were: match score 1, mismatch cost 2, insertion and deletion cost 3. 
The Basic Variant Detection tool was used to detect single nucleotide polymorphisms (SNPs) with a minimum 
coverage of 10 and a minimum reference-to-variant ratio of 35%. Genes that were mutated in at least one sample 
at a frequency above 35% in T18 were then further analysed in T0, T1, T10 and T18 using the Low Frequency 
Variant Analysis tool of CLC Genomics Workbench at a frequency threshold of 2%. All SNPs were then manually 
screened for false positives in regions containing repetitive sequences or hairpins, which caused poor mapping, 
Figure 1. Multiscreen evolution model set-up and experiment overview. (A) The bottom transport receiver 
plate was sterilized by exposure to UV-light and contained either medium (control condition) or a mixed 
bacterial community of S. aureus, S. anginosus, A. xylosoxidans, R. mucilaginosa, and G. haemolysans 
(microbiome condition). The sterile (0.22 µm PDFV) filter plate contained P. aeruginosa AA2 and was placed 
in the receiver plate, with the filters being emerged in the medium. A sterile lid secluded the set-up. (B) Pa 
AA2: P. aeruginosa AA2. Three independent overnight cultures were used to start three independent evolution 
samples = lineages (L1, L2, L3). For each lineage, P. aeruginosa biofilms were evolved in the absence (control) 
or presence of the CF microbial community (microbiome). Sa: S. aureus, Sag: S. anginosus, Ax: A. xylosoxidans, 
Rm: R. mucilaginosa, and Gh: G. haemolysans. T0 is the planktonic overnight culture at the start of the 
experiment, T1 (timepoint 1) is the P. aeruginosa biofilm (BF) obtained after 72 hours of microaerobic growth. 
18 cycles of 72 hours ended in T18 (timepoint 18) after 54 days.
4Scientific RepoRtS |         (2019) 9:12859  | https://doi.org/10.1038/s41598-019-49371-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
or for erroneous reads. The InDels and Structural Variants tool was used to detect insertions and deletions, with 
a p-value threshold of 0.0001. The output was manually screened on mapping patterns of un-aligned read ends 
and only entries with a single breakpoint and identical sequences in the un-aligned read ends were reported. 
The consensus sequence of the un-aligned read ends was then used to confirm the deletion or to identify the 
nature of the inserted sequence. The sequencing raw data is deposited at Array Express under accession number 
E-MTAB-7331.
Sanger sequencing. To verify mutations observed in the WGS data, Sanger sequencing of the lasR and pqsR 
genes of 10 isolates obtained from single colonies was performed. Two primer pairs (Table S2) that amplified 900–
1200 base pair regions were designed targeting the mutated region identified by WGS. After PCR amplification, 
the amplicons were purified using the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel, Germany) and 
sequenced at GATC Biotech (Eurofins Genomics, Germany). Resulting sequences were then inspected visually 
for specific mutations using the Chromas software program (Technelysium Pty Ltd, Australia).
Bacterial growth curves. To compare planktonic growth of all P. aeruginosa AA2 populations, liquid sta-
tionary phase cultures were diluted to approx. 5 × 105 CFU/mL (based on OD590nm) in LB. Of each culture, 100 µL 
was transferred to a PVC 96-well plate (Thermo Fisher Scientific) in triplicate. The 96-well plate was incubated 
statically at 37 °C in the EnVision Multilabel Plate Reader (Perkin Elmer, USA) and OD590nm was measured every 
30 min for 24 hours. After 24 hours, end-point cultures were diluted and plated on LB agar to determine the 
number of CFU.
Quantification of biofilm colony forming units and biomass. P. aeruginosa cultures were diluted in 
LB medium to OD590nm 0.08 (corresponding to ±5 × 107 CFU/mL), where after 100 µL of each culture was trans-
ferred in triplicate to the wells of a flat PVC 96-well plate, and then incubated at 37 °C for 24 hours. Afterwards, 
biofilms were washed and harvested in PS by two cycles of vortexing (5 min, 900 rpm) and sonication (5 min; 
Branson Ultrasonic bath, Hach Company, USA). The resulting cell suspensions were diluted and plated on LB 
plates; after overnight incubation at 37 °C the number of CFU was determined. Biomass of biofilms was quantified 
by crystal violet staining as described previously42,43.
Antibiotic susceptibility testing. Minimal inhibitory concentrations (MIC) for ceftazidime 
(Sigma-Aldrich), aztreonam (TCI Europe), ciprofloxacin (Sigma-Aldrich), colistin (TCI Europe) and tobramy-
cin (TCI Europe) were determined according to the EUCAST guidelines by the microdilution broth method as 
described elsewhere44,45.
Biofilm competition experiment. P. aeruginosa cultures were co-cultured with S. aureus for 24 hours. 
Both were diluted in LB medium to OD590nm 0.08 and 0.2 respectively, corresponding to ±5 × 107 CFU/mL. 
100 µL of mixed culture (50 µL of each) was transferred in triplicate to the wells of a flat PVC 96-well plate, and 
then incubated at 37 °C for 24 hours. Afterwards, the resulting biofilms were loosened and diluted as described 
above, and plated onto selective media to quantify the separate strains. P. aeruginosa and S. aureus were quan-
tified on LB medium supplemented with 1.25 mg/L triclosan and LB medium supplemented with 7.5% NaCl 
respectively39.
Motility assays. Bacterial cultures were diluted to OD590nm = 1 after which three types of motility were tested 
by using media with different agar concentrations: swimming (0.3%), twitching (1.5%) and swarming (0.5%) as 
described before46. Briefly, for determination of swimming and swarming motility, 1 µL of bacterial culture was 
spotted on the surface of LB plates with 0.3% agar or 0.8% nutrient plates with 0.5% glucose and 0.5% agar respec-
tively. For twitching motility, regular LB agar (1.5%) plates were stab-inoculated to the bottom of the petri dish 
with 1 µL of bacterial suspension. All plates were incubated at 37 °C for 48 hours after which bacterial migration 
diameters were measured for swimming and swarming. Twitching was visualized by crystal violet staining as 
previously described46.
Pyoverdine quantification. For pyoverdine quantification, overnight cultures were grown in LB, centri-
fuged, and the resulting supernatant filter-sterilized (0.22 µm). 100 µL of filtered supernatant was transferred 
to a flat PVC 96-well plate and absorbance at 405 nm was measured in the EnVision Multilabel Plate Reader, as 
previously described47.
Pyocyanin quantification. For pyocyanin quantification, liquid cultures were grown in LB broth 
for 24 hours in a shaking warm water bad (37 °C). Supernatants were collected after centrifugation and then 
filter-sterilized (0.22 µm Merck-Millipore filters). Afterwards, a chloroform-HCl extraction was performed to 
determine pyocyanin levels, as described previously48.
Rhamnolipid detection. Semi-quantitative detection of rhamnolipid production by all populations was 
assessed by inoculating 70 µL of bacterial suspension into wells cut out from minimal medium agar plates supple-
mented with 0.05 mg/L methylene blue and 2 mg/L cetyl trimethylammonium bromide (CTAB)49,50. Sizes of blue 
halos were measured after 48 hour incubation at 30 °C and incubation at 4 °C for 48 hours.
Quantification of protease activity. Overnight cultures were grown for 16 hours in LB. Cultures were 
centrifuged and the supernatant filter-sterilized, where after proteolytic activity was determined using an azoca-
sein assay51,52.
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Quantification of N-3-oxododecanoyl-L-homoserine lactone production. Homoserine lactone 
(HSL) signal molecules were first extracted using ethyl acetate as described previously53. Afterwards, 10 µL of con-
centrated HSL molecules was added to 100 µL overnight culture of Escherichia coli (stationary phase culture in LB; 
OD 0.3) containing the reporter plasmid pUCP22NotI-PlasB::gfp(ASV)Plac::lasR which expresses GFP (green 
fluorescent protein) in response to N-3-oxododecanoyl-L-homoserine lactone (3-O-C12-HSL)54,55. Cultures were 
incubated in a black 96-well plate for 24 hours at 37 °C and fluorescence was measured in the EnVision Multilabel 
Plate Reader. The increase in fluorescence over 24 hours is related to the amount of 3-O-C12-HSL present.
Quantification of epithelial cell viability. Cytotoxicity of the bacterial populations was assessed by infec-
tion of an in vivo-like 3-D alveolar epithelial cell culture model (A549 cell line)56–59 and quantified by staining 
with annexin V and propidium iodide, which allows to evaluate host cell apoptosis and necrosis (Alexa Fluor® 
488 Annexin V/Dead Cell Apoptosis Kit, Thermo Fisher Scientific). On the day of infection, 3-D cell aggregates 
were transferred to a 48-well plate at a concentration of 2.5 × 105 cells/well in GTSF-2 medium (Hyclone, USA) 
supplemented with 1.5 g/L sodium bicarbonate (Sigma-Aldrich) and 2.5 mg/L insulin transferring sodium sel-
enite (Lonza). The bacterial suspension was then added to each well, to obtain a targeted MOI (multiplicity 
of infection) of 10:1. After 6 hours of infection, epithelial cells were washed with HBSS (Hank’s Balanced Salt 
Solution, Life Technologies, Thermo Fisher Scientific) and dissociated from the microcarrier bead scaffolds by 
incubation with 250 µL trypsin (0.25%, Life Technologies) for 3 minutes followed by thorough pipetting. The 
trypsinisation reaction was stopped by adding 250 µL GTSF-2 medium with 10% fetal bovine serum (FBS) (Life 
Technologies, Thermo Fisher Scientific). Cells were then harvested by centrifugation and subsequently stained by 
adding 5 µL Alexa Fluor® 488 annexin V and 2 µL propidium iodide (100 µg/mL), according to the manufacturer’s 
instructions. Viability of cells – differentiating between live, necrotic, and apoptotic cells – was analysed by flow 
cytometry (Attune NxT Flow Cytometer, Thermo Fisher Scientific), using excitation at 488 nm and measuring 
fluorescence emission at 530 nm and 575 nm for annexin V and PI, respectively.
Quantification of the NF-κB - mediated inflammatory response. The NF-κB – mediated inflam-
matory response was tested in the above described in vivo-like 3-D alveolar epithelial cell culture model, using 
NF-κB-luciferase-transfected A549 cells (BPS Bioscience, USA). Bacterial cultures and 3-D aggregates were 
diluted in the above-described cell culture medium to result in an MOI of 10:1 and transferred to a 48-well plate. 
After 4 hours of incubation, the supernatant was removed and the 3-D aggregates were transferred to a black 
PVC 96-well plate. The epithelial cells were then lysed and the luciferase substrate added using the ONE-Step 
Luciferase Assay system (BPS Bioscience) according to the manufacturer’s instructions. Luminescence was meas-
ured in the EnVision Multilabel Plate Reader.
Statistical analysis. Statistical analysis was performed in SPSS 24.0. Normality of the data was examined via 
the Shapiro-Wilk test. Normally distributed data were then assessed by an independent samples t-test or one-way 
ANOVA. Not normally distributed data were evaluated using a Mann-Whitney or Kruskal-Wallis non-parametric 
test. Statistical significance of data is assumed when p-values are ≤0.05.
Results
P. aeruginosa AA2 biofilm evolution model. Biofilms grown in the filter plate model (Fig. 1) were inves-
tigated at different time points (24 h, 48 h, 72 h) to determine how long it was possible to co-culture all micro-
biome members (i.e. without losing one or more). As all members of the CF synthetic microbiome remained 
present at the tested time points (Fig. S1), the 72 h co-culture time was selected.
At the end of each 72 h cycle (18 in total), P. aeruginosa AA2 biofilm cells were harvested directly from the 
filter plate and CFUs were immediately determined. For two out of three lineages (L1 and L3), a trend towards 
increased biofilm formation over time was observed, regardless of whether other species were present (Fig. S2). 
When pooling the data of the three lineages, a significant increase in biofilm formation was observed when 
comparing the first (T1) and last (T18) cycle, both in the presence and absence of the microbiome (p < 0.01) 
(Fig. S8A).
We also determined biofilm formation in a conventional PVC microtiter plate starting from preserved cul-
tures of the unevolved strain (T0) or evolved populations (T1, T18) of P. aeruginosa AA2, using plating and crys-
tal violet staining of biomass (Fig. S3). The evolved populations (T18) did not show significant increases in biofilm 
formation after 24 hours in LB. However, when pooling the data of the three lineages, a significant decrease in bio-
film formation was observed between T1 and T18 (p < 0.01) both with and without the microbiome (Fig. S8B). 
Biomass was also significantly reduced in T18 compared to T1 for the pooled samples without the microbiome 
(p < 0.01) (Fig. S8C).
LasR and pqsR mutations occur in the presence and absence of the CF microbial commu-
nity. At the beginning (T1), middle (T10) and at end of the evolution experiment (T18), WGS was performed 
for all evolved P. aeruginosa populations and these sequences were compared to that of the unevolved T0 strain 
(Table S3). Only six genes were found to be mutated at a frequency of ≥ 35% at T18 (Table 1) in at least one lin-
eage, all of these were present in at least two lineages when the lower threshold for frequency was applied. Nine 
genes were mutated at < 35% frequency at T18 (Table S4), and none of these occurred in more than one lineage.
In all P. aeruginosa populations that evolved in the presence and absence of the CF microbial community, 
mutations were found in the lasR QS regulator gene (P. aeruginosa PAO1 homologue designation: PA1430), 
with a frequency (relative abundance of affected reads in the population) of up to 100% already present at T1 
(Table S3). Re-mapping the reads for T0 strain to the AA2 assembly revealed that mutations in lasR were already 
present with a cumulative frequency of 33% in the starting culture (Table S3). These mutations in lasR were the 
only mutations present in T0 or T1.
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Mutations in pqsR (PA1003), another QS regulator gene, were found in all samples at frequencies of up to 93% 
at T10 and T18, these were not found at T1 or T0 (Tables 1, S3). The types of mutations in lasR and pqsR include 
insertions of A/G or a transposase, several deletions, and different SNPs (single nucleotide polymorphisms).
Sample 




































mexL PA3678 SNP G → A (12) 221690 A26T 23
sahH PA0432 SNP G → A (1) 95660 297 nt upstream*c 99
pilA PA4525 Del CTACCA (6) 118729 T154_T155del 97
T18 L1 M
















sahH PA0432 SNP G → A (1) 95660 297 nt upstream 56
pilA PA4525 Del CTACCA (6) 118729 T154_T155del 92
T18 L2 C
lasR PA1430 In +A (2) 294001 S129KfsX104 94

















sahH PA0432 Del ΔG (1) 95633 271 nt upstream 32









pqsR PA1003 SNP A → T (11) 21047 L42Q 59





mexL PA3678 SNP G → C (12) 221695 K27N 23


















































sahH PA0432 SNP G → A (1) 95660 297 nt upstream 77
pilA PA4525 Del CTACCA (6) 118729 T154_T155del 87
T18 L3 M
















sahH PA0432 SNP G → A (1) 95660 297 nt upstream 10
pilA PA4525 Del CTACCA (6) 118729 T154_T155del 93
Table 1. Whole genome sequencing data for evolved (T18) P. aeruginosa populations compared to the starting 
planktonic culture strain (T0). In: insertion (+), Del: deletion (Δ), SNP: single nucleotide polymorphism (→). 
nt: nucleotide. QS: quorum sensing. T18: timepoint 18 (final evolved population). L1, L2, L3: lineage 1, 2, 3. 
C: control (=evolution in the absence of the microbiome), M: microbiome (=evolution in the presence of the 
microbiome). PA number: Pseudomonas aeruginosa PAO1 homologue number. This table lists genes that were 
mutated in at least one sample at a frequency above 35%. *aK182RfsX27: K at position 182 is the first amino acid 
residue affected, it is changed to R followed by a frameshift of 27 codons in total, including the next stop codon. 
*bH173transpos: the codon H at position 173 is interrupted by a transposase. *cThe mutations relating to sahH 
are located in the intergenic region upstream of the start of the gene. *dA34_S37del: the amino acids 34 to 37 are 
deleted. *eV306(pqsA)_S2(phnA)del fsX69: the deletion affects V in position 306 of pqsA to S in position 2 of 
phnA, followed by a frameshift of 69 codons including the stop codon. *fL194_L195insL: L is inserted between 
position 194 and 195.
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Mutations were also found in two other transcriptional regulators. The tetR gene encoding MexL (PA3678, 
part of the TetR protein family), a specific transcriptional repressor of the multidrug efflux operon mexJK60,61, 
was mutated at T18 in all samples that evolved in the absence of the microbiome (at frequencies up to 61%), 
and only in one sample that evolved in the presence of the microbiome. Most mutations in tetR were SNPs. 
Furthermore, in two control samples grown without the microbiome (T18 L1 C; T18 L3 C), mutations in the 
gntR gene (PA4132) were found at frequencies of up to 47% at T18, which were SNPs or insertions. gntR presum-
ably encodes a DNA-binding transcriptional regulator from the MocR family and contains an aminotransferase 
domain, although it has not been fully characterised yet. The mexL, mexJK, and gntR genes have all been shown 
to be QS-activated22.
A deletion was also found in pilA (PA4525), the major pilin of the type IV pili, in all lineages regardless of the 
presence of the microbiome at T10 and T18, at frequencies of up to 97% (Tables 1, S3).
Finally, in all but one (T18 L2 M) samples, a mutation (SNP of G to A, or deletion of G) upstream of sahH 
(PA0432), encoding an adenosylhomocysteinase, was found (Table 1). This mutation consistently occurred at 
lower frequency in the presence of the microbiome (L1: 56 vs 99%, L2: 0 vs 32%, and L3: 10 vs 77%).
Often, different types of mutations occurred in the same gene for the same sample. Yet, it could not be deter-
mined if (or what fraction of) a population contained one or multiple mutations.
Nine genes with low frequency mutations (<35%) were observed at T18 and included the surface attachment 
sensor SagS, two flagellar genes and a type III secretion protein (Table S4).
3-O-C12-HSL and QS-regulated virulence factor production is reduced in evolved popula-
tions. After our discovery of the mutations found in the gene encoding lasR, we measured production of 
3-O-C12-HSL by the T1 and evolved T18 populations using an E. coli biosensor strain expressing GFP in response 
to this QS molecule. Production of 3-O-C12-HSL was significantly reduced in the evolved populations (T18) 
compared to the populations at T1 in all lineages (Fig. 2). This showed that the observed mutations led to a null 
phenotype for the population only at T18, although lasR is already mutated at T1. Pooling the data from three 
lineages confirmed this observation (Fig. S8D).
To evaluate whether the observed mutations in the QS system resulted in downstream differences at the phe-
notypic level, production of QS-regulated virulence factors was quantified (Fig. 3). Pyocyanin production and 
protease activity were significantly reduced in the evolved populations (T18) for all lineages compared to T0 and/
or T1 (both in the absence and presence of microbiome members) (p ≤ 0.05) (Fig. 3), and when all lineages were 
pooled (p ≤ 0.01) (Fig. S8E,F). In the evolved population of lineage 3, rhamnolipid production was also signifi-
cantly reduced (p ≤ 0.05), and when data of all lineages was pooled a significantly lower rhamnolipid production 
was observed between T1 and T18 (Fig. S8G). However, no significant differences in pyoverdine production were 
observed (Figs 3, S8H) and swimming, swarming, and twitching motility were also not affected (Figs S4 and 
S8I–K).
In order to examine whether the differences in virulence factor production were due to potential differences 
in growth, growth curves were determined for evolved and unevolved populations (Figs S5, S8L). In all lineages, 
no differences in growth were observed between all populations in the lag and exponential phases. However, in 
the stationary growth phase, significant differences in absorbance values could be observed between T0 and pop-
ulations from T1 compared to the evolved populations at T18 (p ≤ 0.05). Nevertheless, this could not be linked to 
a change in CFUs (Figs S6, S8M).
Figure 2. Quantification of 3-O-C12-HSL production using an E. coli biosensor strain (expressing GFP 
in response to this molecule). The data is presented as delta fluorescence, by measuring the difference in 
fluorescence at 24 h compared to the start of the experiment, to normalize for autofluorescence. Graphs 
show means, error bars indicate standard deviations. n = 3, *p ≤ 0.05. T0: timepoint 0, planktonic culture. 
T1: timepoint 1, 72 h biofilm cells. T18: timepoint 18, biofilm cells after 18 cycles (54 days). L1: lineage 1, L2: 
lineage 2, L3: lineage 3. C: control P. aeruginosa evolved without microbiome, M: P. aeruginosa evolved with 
microbiome. Neg. ctrl: negative control, pure E. coli culture.
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Finally, the activation of the pro-inflammatory NF-κB pathway was evaluated following exposure of an in 
vivo-like 3-D lung epithelial model to the evolved or unevolved populations. NF-κB pathway activation was 
observed for all populations and no significant differences in activation were observed (p > 0.05) (Figs S7A, S8N). 
Host cell viability was approximately 80% for all infected samples (Figs S7B, S8O).
A mix of lasR and lasR pqsR mutants is present in evolved biofilms. One evolved biofilm (T18 L2 
C) was plated and ten single colonies (C1–C10) were investigated further for mutations in lasR and pqsR using 
Sanger sequencing of the region that was found to be affected by WGS. Theoretically, almost all isolates should 
have the mutation (insertion) in lasR, while only 38% should have the pqsR mutation (SNP), according to the 
WGS data. While Sanger sequencing indeed confirmed that all isolates had a mutation in the lasR gene (10/10, 
100%), six out of ten (60%) isolates also had a pqsR mutation (Table S5).
lasR pqsR  mutants exert lower production of pyocyanin and protease than lasR 
mutants. Pyocyanin and protease production was quantified in two lasR pqsR (C1, C2) and two lasR mutant 
strains (C3, C9) isolated from the evolved control biofilm (T18 L2) in order to assess the role of pqsR in the 
production of these virulence factors. Both pyocyanin production and protease activity were significantly lower 
Figure 3. Determination of pyoverdine (A), pyocyanin (B), protease (C), and rhamnolipid (D) production 
by unevolved and evolved P. aeruginosa AA2  populations. Graphs show means, error bars indicate standard 
deviations. n ≥ 3, *p ≤ 0.05. T0: timepoint 0, planktonic culture. T1: timepoint 1, 72 h biofilm cells. T18: 
timepoint 18, biofilm cells after 18 cycles (54 days). L1: lineage 1, L2: lineage 2, L3: lineage 3. C: control single-
culture, M: microbiome.
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(p ≤ 0.05) in the isolates that contained both mutations (Fig. 4), consistent with previous reports of a regulatory 
role of PQS in pyocyanin and protease production, that are independent of LasR62,63.
Evolved populations show a decreased susceptibility to β-lactam antibiotics. The influence of 
P. aeruginosa evolution in a biofilm in the presence or absence of microbiome members on antibiotic resistance 
was evaluated by testing the susceptibility of unevolved and evolved populations to four antibiotics commonly 
used to treat CF lung infections, each representing a different antibiotic class (Table S6). An increase in the MIC 
for ceftazidime and aztreonam was observed for evolved populations in all lineages, while no differences were 
noticed for ciprofloxacin, colistin, or tobramycin (Fig. 5).
The decreased susceptibility to ceftazidime and aztreonam mostly occurred early in the evolution study with 
an increase in MIC often already observed in T1 compared to T0. In two out of three lineages for both antibiotics, 
the decreased susceptibility was less pronounced in the presence of the microbiome.
The competitive behaviour of evolved populations towards S. aureus is diminished. The frac-
tion of P. aeruginosa and S. aureus present in 24 h dual-species biofilms was quantified on selective media. It was 
observed that in co-culture with evolved P. aeruginosa populations, S. aureus was significantly more present than 
with unevolved populations (T18 compared to T0 and T1) (Figs 6, S8P). Moreover, unevolved P. aeruginosa pop-
ulations (T1) could outcompete S. aureus completely, showing no S. aureus growth in the biofilm, while S. aureus 
growth up to 7 log CFU/mL was observed in biofilms with the evolved populations.
Discussion
In the present study, an early CF P. aeruginosa strain (AA2)64 was used to assess the evolution of biofilms in the 
absence or presence of the common CF lung microbiome members S. aureus, S. anginosus, A. xylosoxidans, R. 
mucilaginosa, and G. haemolysans. Since the CF lung microbiome is typically more diverse prior to P. aeruginosa 
colonization65, it is likely that early colonizers will co-exist with members of the microbiome, which could influ-
ence their evolution. Various phenotypic changes were observed after 18 evolution cycles, including decreased 
production of virulence factors (i.e. pyocyanin, protease, and rhamnolipids). These changes were mostly inde-
pendent of the presence of other bacterial species and are similar to evolutionary changes observed for P. aerugi-
nosa in chronic lung infections in CF patients.
Mutations were discovered in the genes lasR and pqsR, the regulators of two of the QS systems of P. aerugi-
nosa66. The mutations in LasR were already present in the starting culture, and their frequency increased to nearly 
100% in all lineages as early as cycle 1. The in vitro and in vivo loss of function of LasR has been described before 
in adapted P. aeruginosa strains both in planktonic and biofilm cultures6,8,19,23–26, and early genotypic and pheno-
typic changes during experimental evolution of P. aeruginosa have been reported as well67,68. Mutations in lasR 
only occurred after 30 days of biofilm culture in synthetic CF medium for strain PAO168, which is in contrast with 
the results obtained in the present study for a CF clinical isolate. The presence of mutations in lasR at the start of 
Figure 4. Pyocyanin production (A) and protease activity (B) of 2 sets of single isolates (C1 and C2: 
ΔlasRΔpqsR. C3 and C9: ΔlasR) from an evolved strain without microbiome presence (T18 L2 ctrl), selected 
depending on the presence and absence, respectively, of a mutation in pqsR (determined via Sanger sequencing). 
All isolates contained a mutation in lasR. Graphs show means, error bars indicate standard deviations. n ≥ 3, 
*p ≤ 0.05. (C) Photos of isolates C1, C2, C3, and C9 on LB agar showing the visible colour difference in the 
single isolates containing the different mutations.
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Figure 5. MIC values for ceftazidime (CEF) and aztreonam (AZT) in all lineages, for control (ctrl) and 
microbiome (microb) samples. T0: timepoint 0, planktonic start culture. T1: timepoint 1, 72 h biofilm cells. T18: 
timepoint 18, biofilm cells after 18 cycles (54 days). L1: lineage 1, L2: lineage 2, L3: lineage 3.
Figure 6. Determination of competition via dual-species biofilms of P. aeruginosa strains with S. aureus SP123. 
Pa single: P. aeruginosa strains as single-species biofilm, Pa dual: fraction of P. aeruginosa in the dual-species 
biofilm with S. aureus. Sa dual: fraction of S. aureus in the dual-species biofilm with P. aeruginosa. Graphs 
show means and error bars indicate standard deviations. n ≥ 3, *p ≤ 0.05 (S. aureus T18 versus T0 and T1). T0: 
timepoint 0, planktonic start culture. T1: timepoint 1, 72 h biofilm cells. T18: timepoint 18, biofilm cells after 18 
cycles (54 days). L1: lineage 1, L2: lineage 2, L3: lineage 3. C: control single-culture. M: microbiome.
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the evolution study for the CF isolate used in the present study is presumably at the origin of differences with the 
study by Azimi et al.
Despite LasR probably being non-functional at T1, QS-regulated virulence factors (incl. proteases and pyocy-
anin), and 3-O-C12-HSL were still produced by these cultures. In stationary phase, lasR mutants in clinical isolate 
PA14 have been shown to activate QS regulated phenotypes by the rhl QS system replacing the las QS system 
and restoring the production of HSL, virulence factors, and Pseudomonas quinolone signal (PQS)69. It was also 
shown (for PAO1) that PQS production was delayed, but not abolished in a lasR mutant70. Furthermore, recent 
studies described a rewiring of the QS system in CF clinical isolates of P. aeruginosa, where RhlR can activate 
quorum-sensing-dependent genes independently of LasR19.
A subpopulation of P. aeruginosa developed mutations in pqsR, in addition to the mutations in lasR, at later 
stages of evolution. Mutations in pqsR have not been reported as part of the frequent adaptations in the CF lung, 
but have previously been observed in vitro67,71. Mutations in pqsR were associated with a pronounced effect on 
pyocyanin and protease production in our study, which is consistent with a previously described but unresolved 
mechanism by which PQS can activate transcription of these genes in a LasR-independent manner62,63.
PilA, the major pilin of the type IV pilus, was mutated in all lineages, with or without microbiome. Type IV 
pili are involved in biofilm formation in P. aeruginosa, they mediate attachment to surfaces and surface motility72. 
Klausen et al.73 demonstrated (in strain PAO1) that in a pilA/wt mixed biofilm the mutant was only present in 
the stalks of the mushrooms-shaped structures, whereas the wild type formed the caps. Furthermore, a pilApqsA 
double mutant in P. aeruginosa PAO1 only formed surface attached microcolonies and no mushroom-shaped 
structures74. Interestingly, in our study the mutations in pqsR and in pilA seemed to develop in parallel.
The pilA mutation reported in this study is a deletion of a 6 nt duplicated sequence, leading to the deletion of 
two threonine residues out of stretch of four threonines located at the C-terminal of this protein, 3 amino acids 
upstream of the stop codon. PilA in P. aeruginosa AA2 has only 41% similarity to PilA in PAO1, it is more sim-
ilar to PilA in P. aeruginosa K122-4, a clinical isolate from a CF patient in Toronto75. The stretch of threonines 
in which the deletion occurs is not present in the PAO1 PilA. It is therefore unknown if the deletion in PilA of 
strain AA2 has an effect on biofilm phenotype. Nonetheless, the slight decrease in biofilm formation of evolved 
populations (which was observed when pooling the data of all lineages), as well as the low frequency of mutations 
in flagellar genes and SagS point to a modulation of attachment and biofilm formation in evolved populations. 
While the ability of the evolved population to form new biofilms was decreased (probably due to the described 
genotypic changes), the biofilm formation during evolution increased over time. We speculate that this could be 
due to phenotypic alterations, such as accumulation of extracellular matrix components during transfers when 
starting new biofilm cycles.
A decrease in susceptibility to the β-lactam antibiotics ceftazidime and aztreonam was observed for all evolved 
P. aeruginosa populations. Evolution of antibiotic resistance in response to continuous antibiotic stress is com-
mon76,77. However, in our study set-up, no antibiotics were present. Davies et al.78 and D’Argenio et al.8 also 
observed this increase in MIC for ceftazidime with evolved P. aeruginosa strains in the absence of antibiotics. 
This was attributed to an elevated production of β-lactamases by QS mutant strains. Although no mutations were 
found in either ampC or poxB, the described co-regulation between AmpR, a β-lactamase expression regulator, 
and LasR could explain the observed increase in resistance8,79,80. Additionally, in the WGS data, a mutation was 
observed in the gene encoding MexL, a TetR family repressor of the multidrug efflux pump MexJK. This muta-
tion was more frequently observed in lineages that evolved in the absence of the microbiome, and could possibly 
explain the more pronounced increase in the MIC of β-lactam antibiotics under these conditions. Nevertheless, 
MexJK has only been shown to transport tetracycline, erythromycin, and triclosan in P. aeruginosa60,61, and the 
potential transport of β-lactam antibiotics by the MexJK efflux pump remains to be investigated.
Finally, the competitive behaviour of P. aeruginosa in a dual-species biofilm with S. aureus was investigated, 
showing that unevolved populations outcompete S. aureus, while evolved populations allowed ample S. aureus 
biofilm growth. Co-cultures of P. aeruginosa and S. aureus have been studied extensively and mostly show P. 
aeruginosa outcompeting S. aureus in vitro (reviewed in81). Yet, in vivo, concomitant infections of both pathogens 
are often seen82. Here, we show that evolutionary adaptation of P. aeruginosa leads to a less competitive pheno-
type. These results can most likely be explained by the observed mutations in lasR and pqsR and downstream 
effects on the production of QS molecules and virulence factors (such as proteases, pyocyanin), which have been 
shown to affect S. aureus growth and/or viability81. For example, mutations in P. aeruginosa leading to impaired 
2-hydroxy-4-alkylquinolone production – which is regulated by the PQS QS system - reduced the growth inhibi-
tion of S. aureus, normally inflicted by the wild-type strains83,84.
In a recent evolution study by Tognon et al.24, P. aeruginosa and S. aureus were co-cultured as dual-species bio-
films, but a lasR mutation was only observed in monocultures of P. aeruginosa, and not in co-cultured samples. 
In our study, lasR mutations increased in frequency regardless of whether other species were present. However, 
in our model the community was more diverse and no direct interactions occurred between different species, 
in contrast to previous studies. As the spatial organization of complex communities influences metabolism and 
co-evolution of multispecies communities85, this could explain differences between the present study and previ-
ous work24. However, the lack of direct contact may be more reflective of the in vivo situation in the CF lungs, as 
bacteria are often found as separate single species microcolonies in sputum of CF patients, rather than as truly 
intermixed communities4,86.
In the present study, we performed phenotypic and genotypic analysis of the whole evolved population. With 
this approach, possible effects of evolution on population diversification in the presence or absence of the micro-
biome were not considered. Phenotypic diversity in the CF lung environment is frequently observed for P. aerug-
inosa and other CF pathogens5,87, which is possibly related to regional adaptation18. In vitro evolution studies 
have also reported P. aeruginosa diversification during biofilm growth, with variation in antibiotic resistance and 
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colony morphology being observed78,88. Whether interspecies interactions between the members of the microbi-
ome could influence P. aeruginosa population diversity remains to be determined.
In conclusion, we showed that in vitro evolution of P. aeruginosa AA2 biofilms can lead to pathoadaptive 
mutations and phenotypes commonly found in in vivo chronic infections. The most noticeable genotypic and 
phenotypic changes, which are related to the las and pqs QS machineries, occurred regardless of the presence of 
other members of the CF microbiome. Understanding the in vivo factors that drive and/or modulate the evolu-
tionary behaviour of P. aeruginosa may lead to novel therapeutic avenues to direct evolution towards a genotype/
phenotype that is susceptible to treatment.
Data Availability
All data is available in this manuscript, the Supplemental Information or deposited in databases, as described in 
the manuscript.
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